Scientific Advisory Board

Scientific Advisory Board

A scientific Advisory Board has been convened to advise the HCU Networks on key priorities and guide which specific projects should be funded.

The current members of the Scientific Advisory Board include:


Professor Viktor Kožich, (Chair of SAB); MD, PhD, Professor of Medical Genetics,
Department of Pediatrics and Inherited Metabolic Diseases, General University Hospital in Prague and Charles University-First Faculty of Medicine, Prague, Czech Republic. Read Professor Kožich’s bio


Professor Matthias R. Baumgartner, Prof. Dr. med., head of Division for Metabolic Diseases and Medical Director of the Swiss Newborn Screening Program, University Children’s Hospital Zurich, Zürich, Switzerland. Read Professor Baumgartner's bio


Professor Henk Blom, Laboratory Specialist Clinical Genetics, Center for Lysosomal and Metabolic Diseases, Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, Netherlands; Professor, Biochemistry of Inherited Metabolic Disease Read Professor Blom's bio


Dr Kimberly Chapman, MD, Ph.D., attending physician in Genetics and Metabolism, Children’s National: Assistant Professor of Pediatrics and Integrated Systems Biology, George Washington University, U.S. Read Dr. Chapman's bio


Professor Warren Kruger, Ph. D, Full professor, Cancer Biology and Epigenetics program at Fox Chase Cancer Center, Philadelphia, PA, U.S. Read Professor Kruger's bio


Dr Andrew Morris, BM, BCh, PhD, Consultant and Senior Lecturer in Paediatric Metabolic Medicine, Willink Metabolic Unit, Manchester University Hospitals NHS Trust, UK. Read Dr. Morris' bio 

Patient Representatives:


Margaret McGlynn, R. Ph., Hon DSc, President of Board, HCU Network America


Tara Morrison, BA LLB, Director and Chair, HCU Network Australia

Responsibilities of the Scientific Advisory Board

The responsibilities of the Scientific Advisory Board include:

  • Work with HCU Network America and HCU Network Australia (HCUNAs) (and other patient groups interested in funding grants) to develop research strategy and identify key priorities for funding.
  • Provide non-binding but informed guidance on matters specific to HCUNAs research and funding strategies, including opportunities for new programs or clinical trials.
  • Provide peer review for applications submitted to HCUNAs for funding and provide recommendations on specific projects to be funded.
  • Support any grant applications submitted by HCUNAs to other funding bodies.
  • Participate in periodic reviews of HCUNAs Research Strategy.

Download a copy of the Scientific Advisory Board’s Terms of Reference.

Past members of the Scientific Advisory Board include:


The Late Professor Jan Kraus, Ph. D, Professor Pediatrics / Cell and Developmental Biology, University at Colorado U.S. and  posthumous recipient of HCU Hero Award from HCU Network America Read Professor Kraus' bio